Eighty percent of the patients had diabetes, and 41 percent already had coronary artery disease. Before banding, the average flow in the fistulas was 3,784 mL/min.
To track clinical improvements, the Transonic hemodialysis monitor was used to measure cardiac output and access flow every two weeks after the banding procedure and again at three and six months. 2D echo was performed at six months post-banding, in addition to the access flow measurements and clinical evaluation.
The clinicians found that by reducing the fistula flows to a mean of 1174 mL/min, their patients’ cardiac outputs decreased significantly as did their pulmonary systolic pressures and left ventricular mass indices. In fact, their heart failure (according to the New York Heart Association’s classification system) improved by one stage. Moreover, their need to return to a hospital for acute heart failure decomposition decreased significantly.
With the aid of a Transonic hemodialysis monitor for aggressive post-banding surveillance, the clinicians were able to substantiate the therapeutic benefits of banding their patients with high-flow fistulas to avert cardiac overload and reduce their need for hospitalization.
Side Bar:
The widely used New York Heart Association (NYHA) heart failure classification
Reference
Balamuthusamy S, Jalandhara N, Subramanian A, Mohanaselvan A. “Flow reduction in high-flow arteriovenous fistulas improve cardiovascular parameters and decreases need for hospitalization,” Hemodial Int. 2016 Jul;20(3):362-8. (Transonic Reference # HD11223AH).